CSPC Pharmaceutical Group (1093) Income Statement

30 Followers

CSPC Pharmaceutical Group Income Statement

Last quarter (Q4 2025), CSPC Pharmaceutical Group's total revenue was HK$13.94B, a decrease of -7.30% from the same quarter last year. In Q4, CSPC Pharmaceutical Group's net income was HK$1.46B. See CSPC Pharmaceutical Group’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Total Revenue	HK$ 28.20B	HK$ 29.54B	HK$ 31.47B	HK$ 31.59B	HK$ 27.41B
Gross Profit	HK$ 18.50B	HK$ 20.67B	HK$ 22.19B	HK$ 22.73B	HK$ 20.79B
Operating Expenses	HK$ 14.19B	HK$ 15.22B	HK$ 15.19B	HK$ 15.80B	HK$ 14.64B
Depreciation and Amortization	HK$ 1.53B	HK$ 1.36B	HK$ 1.11B	HK$ 1.07B	HK$ 849.47M
EBITDA	HK$ 5.84B	HK$ 7.18B	HK$ 8.59B	HK$ 8.85B	HK$ 7.57B
Operating Income	HK$ 4.31B	HK$ 5.45B	HK$ 7.01B	HK$ 6.93B	HK$ 6.14B
Other Income/Expenses	HK$ 907.87M	HK$ 229.71M	HK$ 388.72M	HK$ 811.55M	HK$ 591.96M
Pretax Income	HK$ 5.21B	HK$ 5.68B	HK$ 7.39B	HK$ 7.74B	HK$ 6.73B
Net Income	HK$ 4.21B	HK$ 4.41B	HK$ 5.88B	HK$ 6.22B	HK$ 5.51B
Per Share Metrics
Basic EPS	HK$ 0.37	HK$ 0.38	HK$ 0.50	HK$ 0.52	HK$ 0.46
Diluted EPS	HK$ 0.37	HK$ 0.38	HK$ 0.49	HK$ 0.52	HK$ 0.46
Weighted Average Shares Outstanding	11.42B	11.74B	11.87B	11.92B	11.95B
Weighted Average Shares Outstanding (Diluted)	11.42B	11.74B	11.87B	11.92B	11.95B

Currency in HKD

CSPC Pharmaceutical Group (1093) Income Statement

CSPC Pharmaceutical Group Income Statement

CSPC Pharmaceutical Group Earnings and Revenue History